Illustration: Sarah Grillo/Axios

The renewable power sector would not get sought-after aid in the COVID-19 economic plans before lawmakers on Capitol Hill, a setback for the industry warning of steep job losses and scuttled projects.

Driving the news: House Democrats' $2.5 trillion proposal unveiled last night omits what industry groups and some lawmakers wanted: an extension of deadlines to use tax credits and the ability to quickly monetize them. The provisions are also absent from the Senate's GOP-drafted "phase three" proposal.

The intrigue: There may be room for negotiation. The House plan lacks White House-backed language in the Senate bill that would provide $3 billion to buy oil for the Strategic Petroleum Reserve.

What they're saying: Rep. Kathy Castor (D-Fla.), who heads the House Select Committee on the Climate Crisis and is among the lawmakers seeking the renewables' aid, tells Axios she'll fight to include the provisions in the "phase three" bill.

  • "As President Trump and Sen. McConnell insist on bailing out polluters through the COVID stimulus bill, my Democratic colleagues and I will keep fighting to protect the millions of clean energy workers affected by this crisis."

But, but, but: While the industry hasn’t given up on this round, a push in a subsequent COVID-19 aid package is possible.

  • The absence of the provisions in the measure Speaker Nancy Pelosi unveiled last night signals that they're not among Democratic leadership's priorities in this round.
  • Senate Majority Leader Mitch McConnell and other Republicans are attacking Democrats for efforts to include renewable tax provisions and other climate-related measures in "phase three."
  • And, this morning, President Trump via Twitter attacked efforts to put green provisions into the stimulus.
  • Democrats' leverage is limited, given GOP control of the White House and Senate and the need to quickly take steps to shore up the collapsing economy.

Go deeper:

Go deeper

Dan Primack, author of Pro Rata
32 mins ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Updated 33 mins ago - Politics & Policy

House Democrats and Trump admin strike deal to avert government shutdown

House Speaker Nancy Pelosi on Capitol Hill. Photo: Tom Williams/CQ-Roll Call via Getty Images

The House on Tuesday passed legislation to fund the government through Dec. 11, by a vote of 359-57.

Why it matters: The bill will avert a government shutdown when funding expires in eight days. Pelosi and House Majority Leader Steny Hoyer (D-Md.) said earlier that they hoped to hold a vote on the legislation on Tuesday evening.

Scoop: Meadows puts agencies on notice about staff shake-up

Internal government email obtained by Axios

White House chief of staff Mark Meadows told administration officials Monday to expect senior aides to be replaced at many government agencies, according to an internal email obtained by Axios.

Behind the scenes: Meadows asked the director of the White House Presidential Personnel Office John McEntee "to look at replacing the White House Liaisons (WHLs) at many of your agencies," according to the email. "John will be working with outgoing liaisons to explore other opportunities."

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!